Product logins

Find logins to all Clarivate products below.


Clarivate’s Pharma Industry Report provides pharma executives with a comprehensive summary of the current and future state of the global pharmaceutical industry.

Scope

This report pulls together key information about the global pharmaceutical market from across our Company & Drug Insights content. We analyze the top selling brands, companies, and therapeutic areas. We evaluate the leading competitors in terms of their ethical drug sales, strategic focus, current drivers, patent exposure, and pipeline projects. We compare the different therapeutic areas in terms of their global sales and highlight the leading competitors and pipeline drugs within each area to provide you with a comprehensive summary of the global market.

Companies Mentioned

  • AbbVie
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi-Sankyo
  • Eisai
  • Eli Lilly
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
  • Teva
  • Vertex

Questions answered in this report

  • Who are the leading competitors in the global pharmaceutical industry? What are their current drivers and areas of R&D? What is their timeline for patent exposure?
  • How do the different therapy areas rank in terms of size and relative growth? How do their global sales break down by drug technology, and what are the leading pipeline projects?
  • What are the leading drugs according to global sales, and how will these rankings change by 2028?

 

Related Market Assessment Reports

Report
Primary Biliary Cholangitis – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Primary biliary cholangitis (PBC) is a rare autoimmune liver disease, characterized by inflammation and progressive damage leading to destruction of interlobular bile ducts, followed by cholestasis…
Report
Schizophrenia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Schizophrenia (US)
Schizophrenia is a highly drug-treated condition that uses an array of medications, including atypical and typical antipsychotics, resulting in a complex treatment algorithm. Although this drug…
Report
Rheumatoid Arthritis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Rheumatoid Arthritis (US)
The treatment of rheumatoid arthritis (RA) typically begins with cost-effective conventional DMARDs (cDMARDs) such as methotrexate or hydroxychloroquine. For patients who fail cDMARD treatment or…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Reduced Ejection Fraction (US)
Drug treatment of heart failure with reduced ejection fraction (HFrEF) is well established, backed by a wealth of supporting evidence from clinical trials. RAAS inhibitors and beta blockers are the…
Report
Immune Thrombocytopenic Purpura – Current treatment – Treatment Algorithms: Claims Data Analysis – Immune Thrombocytopenic Purpura (US)
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet count, resulting in an increased risk of bleeding. Current therapies for ITP can be largely divided…